<DOC>
	<DOCNO>NCT00134602</DOCNO>
	<brief_summary>The purpose study develop evaluate intervention promote adherence HIV medication among child 5-12 year age . It compare change antiretroviral ( ARV ) adherence EIG ( enhance intervention group ) MIG ( minimal intervention group ) baseline 4 month post-intervention . Secondary outcome include examine whether improvement adherence medication regimen associate improved health outcome ( i.e. , viral load , CD4 count , etc . ) ; identify evaluate predictor and/or mediator adherence ; study feasibility electronic record measure adherence HIV-infected pediatric population ; evaluate relationship amount intervention receive ( i.e. , number hours/number session ) change adherence .</brief_summary>
	<brief_title>Pediatric Impact : Promoting Adherence Medications Among HIV-infected Children</brief_title>
	<detailed_description>The objective research develop evaluate intervention promote adherence HIV-medications among child age 5-12 year . The research conduct Jacobi Medical Center Bronx , NY ; Children 's National Medical Center Washington , DC ; Howard University Hospital Washington , DC . The research employ randomize case control study design . Participants ( dyad compose HIV-infected child his/her primary caregiver ) recruit eligible family within site 's HIV clinic . After study explain informed consent assent ( applicable ) obtain , participant randomly assign either enhanced intervention group ( case ) minimal intervention group ( control ) . Participants assign enhanced intervention group receive multi-component intervention , specifically tailor family 's need , include maximum 24 hour contact conducted period 12-weeks , 1-3 hour booster session approximately six week intervention phase complete . The enhanced intervention coordinate onsite Adherence Coordinator ( AC ) implement primarily AC another member study staff . Participants assign comparison group receive minimal intervention consist educational video health education pamphlets general health . All participant continue receive standard-of-care respective site study period . Assessments participant do baseline ( Assessment A ) , 1 month ( Assessment B ) , 4 month ( Assessment C ) follow intervention . Each assessment include interview collect follow information family : - socio-demographic data ; - parental/child report child 's medication take adherence ( self-reported adherence ) ; - mental health functioning ( parent child , use standardized measure ) ; - HIV ( parent ) medication knowledge ( parent child ) ; - medical review child 's hospital chart . The baseline assessment adherence medication include electronic record medication take via MEMSÂ® cap do four-week period . Ongoing electronic assessment adherence occur duration study . Pharmacy refill data also obtain portion study participant data available .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Families child age 5 12 year old HIVinfected receives care participate hospital Informed consent assent child Informed consent primary caregiver ( person responsible child 's medication delivery ) must obtain . The parent/legal guardian must able give informed consent willing comply protocol requirement . The HIVinfected child must currently prescribe antiretroviral therapy regimen . The child caregiver respond selfreport question cognitive impairment . The child receive home health care home health care aide dispense child 's medication ( essentially result directly observe therapy child ) . The child and/or caretaker speak English Spanish .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>HIV infection , antiretroviral therapy , adherence , pediatric</keyword>
</DOC>